These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 15125786)

  • 1. Female premenopausal fracture risk is associated with gc phenotype.
    Lauridsen AL; Vestergaard P; Hermann AP; Moller HJ; Mosekilde L; Nexo E
    J Bone Miner Res; 2004 Jun; 19(6):875-81. PubMed ID: 15125786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma concentrations of 25-hydroxy-vitamin D and 1,25-dihydroxy-vitamin D are related to the phenotype of Gc (vitamin D-binding protein): a cross-sectional study on 595 early postmenopausal women.
    Lauridsen AL; Vestergaard P; Hermann AP; Brot C; Heickendorff L; Mosekilde L; Nexo E
    Calcif Tissue Int; 2005 Jul; 77(1):15-22. PubMed ID: 15868280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic variation in two bone-related proteins: is there an association with bone mineral density or skeletal size in postmenopausal women?
    Eichner JE; Cauley JA; Ferrell RE; Cummings SR; Kuller LH
    Genet Epidemiol; 1992; 9(3):177-84. PubMed ID: 1521779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of an insulin-like growth factor I gene promoter polymorphism on hip bone geometry and the risk of nonvertebral fracture in the elderly: the Rotterdam Study.
    Rivadeneira F; Houwing-Duistermaat JJ; Beck TJ; Janssen JA; Hofman A; Pols HA; Van Duijn CM; Uitterlinden AG
    J Bone Miner Res; 2004 Aug; 19(8):1280-90. PubMed ID: 15231015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of the macrophage activating factor (MAF) precursor activity with polymorphism in vitamin D-binding protein.
    Nagasawa H; Sasaki H; Uto Y; Kubo S; Hori H
    Anticancer Res; 2004; 24(5C):3361-6. PubMed ID: 15515432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A common methylenetetrahydrofolate reductase (C677T) polymorphism is associated with low bone mineral density and increased fracture incidence after menopause: longitudinal data from the Danish osteoporosis prevention study.
    Abrahamsen B; Madsen JS; Tofteng CL; Stilgren L; Bladbjerg EM; Kristensen SR; Brixen K; Mosekilde L
    J Bone Miner Res; 2003 Apr; 18(4):723-9. PubMed ID: 12674333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteoporosis risk in premenopausal women.
    Vondracek SF; Hansen LB; McDermott MT
    Pharmacotherapy; 2009 Mar; 29(3):305-17. PubMed ID: 19249949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive value of low BMD for 1-year fracture outcomes is similar for postmenopausal women ages 50-64 and 65 and Older: results from the National Osteoporosis Risk Assessment (NORA).
    Siris ES; Brenneman SK; Miller PD; Barrett-Connor E; Chen YT; Sherwood LM; Abbott TA
    J Bone Miner Res; 2004 Aug; 19(8):1215-20. PubMed ID: 15231007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteoporosis and fracture risk in women of different ethnic groups.
    Barrett-Connor E; Siris ES; Wehren LE; Miller PD; Abbott TA; Berger ML; Santora AC; Sherwood LM
    J Bone Miner Res; 2005 Feb; 20(2):185-94. PubMed ID: 15647811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rate of forearm bone loss is associated with an increased risk of fracture independently of bone mass in postmenopausal women: the OFELY study.
    Sornay-Rendu E; Munoz F; Duboeuf F; Delmas PD
    J Bone Miner Res; 2005 Nov; 20(11):1929-35. PubMed ID: 16234965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of the G-174C variant in the interleukin-6 promoter region with bone loss and fracture risk in older women.
    Moffett SP; Zmuda JM; Cauley JA; Stone KL; Nevitt MC; Ensrud KE; Hillier TA; Hochberg MC; Joslyn G; Morin P; Cummings SR;
    J Bone Miner Res; 2004 Oct; 19(10):1612-8. PubMed ID: 15355555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of osteopenic women at high risk of fracture: the OFELY study.
    Sornay-Rendu E; Munoz F; Garnero P; Duboeuf F; Delmas PD
    J Bone Miner Res; 2005 Oct; 20(10):1813-9. PubMed ID: 16160738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type I collagen racemization and isomerization and the risk of fracture in postmenopausal women: the OFELY prospective study.
    Garnero P; Cloos P; Sornay-Rendu E; Qvist P; Delmas PD
    J Bone Miner Res; 2002 May; 17(5):826-33. PubMed ID: 12009013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment with alendronate prevents fractures in women at highest risk: results from the Fracture Intervention Trial.
    Ensrud KE; Black DM; Palermo L; Bauer DC; Barrett-Connor E; Quandt SA; Thompson DE; Karpf DB
    Arch Intern Med; 1997 Dec 8-22; 157(22):2617-24. PubMed ID: 9531231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin D and calcium-sensing receptor genotypes in men and premenopausal women with low bone mineral density.
    Eckstein M; Vered I; Ish-Shalom S; Shlomo AB; Shtriker A; Koren-Morag N; Friedman E
    Isr Med Assoc J; 2002 May; 4(5):340-4. PubMed ID: 12040821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Sp1 binding site polymorphism in the COLIA1 gene predicts osteoporotic fractures in both men and women.
    Langdahl BL; Ralston SH; Grant SF; Eriksen EF
    J Bone Miner Res; 1998 Sep; 13(9):1384-9. PubMed ID: 9738510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin D receptor gene polymorphisms and the risk of fractures in older women. For the Study of Osteoporotic Fractures Research Group.
    Ensrud KE; Stone K; Cauley JA; White C; Zmuda JM; Nguyen TV; Eisman JA; Cummings SR
    J Bone Miner Res; 1999 Oct; 14(10):1637-45. PubMed ID: 10491209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone mineral density and bone loss measured at the radius to predict the risk of nonspinal osteoporotic fracture.
    Gnudi S; Malavolta N; Lisi L; Ripamonti C
    J Bone Miner Res; 2001 Jun; 16(6):1130-5. PubMed ID: 11393790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The influence of hormonal replacement therapy on bone density in postmenopausal women depending on polymorphism of vitamin D receptor (VDR) and estrogen receptor (ER) genes].
    Brodowska A
    Ann Acad Med Stetin; 2003; 49():111-30. PubMed ID: 15552843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low BMD is less predictive than reported falls for future limb fractures in women across Europe: results from the European Prospective Osteoporosis Study.
    Kaptoge S; Benevolenskaya LI; Bhalla AK; Cannata JB; Boonen S; Falch JA; Felsenberg D; Finn JD; Nuti R; Hoszowski K; Lorenc R; Miazgowski T; Jajic I; Lyritis G; Masaryk P; Naves-Diaz M; Poor G; Reid DM; Scheidt-Nave C; Stepan JJ; Todd CJ; Weber K; Woolf AD; Roy DK; Lunt M; Pye SR; O'neill TW; Silman AJ; Reeve J
    Bone; 2005 Mar; 36(3):387-98. PubMed ID: 15777673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.